Amoy Diagnostics Co., Ltd. engages in the research, development, production, and sale of tumor precision molecular diagnostic products. It offers molecular diagnostic reagents, drug testing equipment, technical consultation, and related testing services. The company was founded by Li Mou Zheng on February 21, 2008 and is headquartered in Xiamen, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company